Barbie Boosts Profits, but Strikes and Ad Market Woes Loom

Barbie

VIP LIVEALERTS-PRO Barbie Woes Loom As Shares Tank Barbie Boosts Profits, but Strikes and Ad Market Woes Loom Warner Bros Discovery (WBD) has exceeded core quarterly profit estimates due to the blockbuster success of “Barbie” at the box office. However, ongoing Hollywood strikes and a sluggish advertising market could impact earnings into the next year. […]

PaxMedica Announces Publication of Its Autism Spectrum Disorder

PaxMedica

VIP LIVEALERTS-PRO PaxMedica shares surge 180% PaxMedica Announces Publication of Its Autism Spectrum Disorder Phase 2 Study Results in Peer-reviewed Journal Tuesday, 07 November 2023 08:00 TARRYTOWN, NY / ACCESSWIRE / November 7, 2023 / PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, announced the publication of research findings in the Annals […]

Massive Profits: VipLiveAlerts-Pro’s Stock Pick Skyrockets 4000%

Massive Profits

In a stunning turn of events, VipLiveAlerts-Pro’s latest stock pick soared an astonishing 4000% after receiving early pre-market alerts at $1.20. Members who acted swiftly were rewarded with massive profits, as the stock’s value skyrocketed. This success story serves as a testament to the power of VipLiveAlerts-Pro’s expert analysis and timely recommendations.

Biocept Signs CNSide™ Licensing Agreement

Biocept

VIP LIVEALERTS-PRO Biocept Signs CNSide™ Licensing Agreement Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics September 08, 2023 08:00 AM Eastern Daylight Time   SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces the signing of a non-exclusive licensing agreement for CNSide™ with Plus Therapeutics, Inc. (Nasdaq: PSTV) […]

Taysha gene therapies reports initial clinical data

Taysha gene therapies

VIP LIVEALERTS-PRO Taysha Gene Therapies, Inc Taysha gene therapies reports initial clinical data from first adult rett syndrome patient dosed in reveal phase 1/2 trial and provides corporate update with second quarter 2023 financial results Data from first adult patient dosed in REVEAL Phase 1/2 trial showed TSHA-102 was well-tolerated with no treatment-emergent serious adverse […]

Missfresh Announces Entry of Share Purchase Agreements

Missfresh

VIP LIVEALERTS-PRO Missfresh Share Purchase Agreements Missfresh Announces Entry of Share Purchase Agreements for Financing and Business Acquisition BEIJING, Aug. 03, 2023 (GLOBE NEWSWIRE) — Missfresh Limited (“Missfresh” or the “Company”) (NASDAQ: MF), today announced that it entered into two share purchase agreements with two investors, respectively (the “Share Purchase Agreements for Financing”), and another […]

Walgreens Boots Alliance Sells Remaining Shares

Missfresh

VIP LIVEALERTS-PRO Walgreens Boots Alliance Walgreens Boots Alliance Sells Remaining Shares of Option Care Health for Approximately $330 Million of Proceeds Transaction Highlights Walgreens Boots Alliance announces the sale of its remaining shares of Option Care Health for proceeds of approximately $330 million Proceeds to Walgreens Boots Alliance will be used primarily for debt paydown, […]

Apple Vision Pro: Apple’s first spatial computer

Apple Vision Pro

VIP LIVEALERTS-PRO Apple Vision Pro™ Introducing Apple Vision Pro: Apple’s first spatial computer Introducing the era of spatial computing with Apple Vision Pro. (Photo: Business Wire) June 05, 2023 03:03 PM Eastern Daylight Time CUPERTINO, Calif.-(BUSINESS WIRE)-Apple® today unveiled Apple Vision Pro™, a revolutionary spatial computer that seamlessly blends digital content with the physical world, […]

Silicon Valley Bank shares fall 64% in pre-market trading

Silicon Valley Bank

VIP LIVEALERTS-PRO Silicon Valley Bank Financial Group SVB Financial Group Announces Proposed Offerings of Common Stock and Mandatory Convertible Preferred Stock SANTA CLARA, Calif., March 8, 2023 /PRNewswire/ — SVB Financial Group (“SVB”) (NASDAQ: SIVB), announced today that it intends to offer $1.25 billion of its common stock and $500 million of depositary shares, consisting of 10 million depositary shares each representing […]

Ambrx to Commence Trading on Nasdaq

TradingView Stock charts

VIP LIVEALERTS-PRO Ambrx on Nasdaq Today Company to Transfer Stock Exchange Listing from NYSE to Nasdaq Ticker symbol will remain “AMAM” March 06, 2023 09:00 AM Eastern Standard Time   SAN DIEGO–(BUSINESS WIRE)–Ambrx Biopharma Inc. (NYSE: AMAM) (“Ambrx” or “the Company”) today announced that it will voluntarily transfer its stock exchange listing to the Nasdaq […]